Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 1—January 2025
Research
Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48–Like Carbapenemases, Israel, 2007–2023
Table 2
Classification | No. (%) |
---|---|
Initial classification | |
Nosocomial† | 750 (42.9) |
Nonnosocomial |
1,000 (57.1) |
Reclassification of non-nosocomial after investigation‡ | |
Healthcare-associated | 518 (51.8) |
Imported§ | 53 (5.3) |
Community-acquired |
429 (42.9) |
Community-acquired as % of all cases | 429 (24.5) |
*OXA-EC, Escherichia coli producing OXA-48–like carbapenemases. †Detected >48 hours after hospital admission, upon transfer, or upon readmission within 30 days. ‡Percentages indicate percentages of patients with acquisition initially classified as nonnosocomial. §Includes cases in residents of Israel reporting recent foreign travel, tourists, medical tourists, and foreign workers.
1Members of the working group are listed at the end of this article.
Page created: December 02, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.